Paid Clinical Trials in Nevada

Nevada has 550 paid clinical trials enrolling now across cities including Las Vegas, Reno and Henderson. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

511 clinical trials

Get a weekly email when new trials open in Las Vegas, NV.

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

for HIV Infections

Sites in Las Vegas +34 more locations

Sponsor: ViiV Healthcare

Sex: All·Age: 12+

Code: NCT07650916·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

for Obesity

Sites in Las Vegas +70 more locations

Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Sex: All·Age: 18 - 79

Code: NCT07654361·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

for Multiple Myeloma (MM)

Drug: Elranatamab

Sites in Las Vegas +5 more locations

Sponsor: SCRI Development Innovations, LLC

Sex: All·Age: 18+

Code: NCT07637578·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

for Liver Fibrosis

Sites in Las Vegas +19 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07610837·Phase 2·Recruiting·Listed May 2026

Apply to this trial

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

for Obesity & Overweight

Sites in Las Vegas +1 more location

Sponsor: Corxel Pharmaceuticals

Sex: Female·Age: 18 - 55

Code: NCT07652047·Phase 1·Recruiting·Listed Jun 2026

Apply to this trial

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

for Overweight (BMI > 25)

Sites in Las Vegas +1 more location

Sponsor: Midwest Center for Metabolic and Cardiovascular Research

Sex: All·Age: 21 - 74·Accepts healthy volunteers

Code: NCT07566325·Recruiting·Listed May 2026

Apply to this trial

RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder

for Overactive Bladder (OAB)

1 location in Reno

Sponsor: Vensica Therapeutics Ltd.

Sex: Female·Age: 18 - 80

Code: NCT07553065·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Drug: Divarasib

Sites in Reno +4 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07541170·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

for Acne Vulgaris

Sites in Las Vegas +14 more locations

Sponsor: Bausch Health Americas, Inc.

Sex: All·Age: 9 - 11

Code: NCT07524946·Phase 4·Recruiting·Listed Apr 2026

Apply to this trial

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for Rhabdomyosarcoma

Sites in Reno +84 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 50

Code: NCT07466316·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

for Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

Drug: Solriamfetol

Sites in Las Vegas +39 more locations

Sponsor: Axsome Therapeutics, Inc.

Sex: All·Age: 18 - 65

Code: NCT07484217·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

for Schizophrenia

Sites in Las Vegas +41 more locations

Sponsor: MapLight Therapeutics

Sex: All·Age: 18 - 65

Code: NCT07459647·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

for Glioblastoma, IDH-Wildtype

Sites in Reno +53 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT07452458·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Study of VV-14305 for the Treatment of Thyroid Eye Disease

for Thyroid Eye Disease (TED)

Sites in Las Vegas +2 more locations

Sponsor: Kriya Therapeutics, Inc.

Sex: All·Age: 18 - 80

Code: NCT07404111·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

for Fibromyalgia

Sites in Las Vegas +52 more locations

Sponsor: Axsome Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07398417·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

52-week Open Label Safety-Tolerability Study

for Schizophrenia

Sites in Las Vegas +22 more locations

Sponsor: LB Pharmaceuticals Inc.

Sex: All·Age: 18 - 65

Code: NCT07369154·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery

for Ureter Injury

Sites in Las Vegas +8 more locations

Sponsor: Intuitive Surgical

Sex: All·Age: 16 - 75

Code: NCT07346066·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis (IPF)

Sites in Reno +9 more locations

Sponsor: PureTech

Sex: All·Age: 40+

Code: NCT07284602·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

for Pulmonary Hypertension Associated With HFpEF

Sites in Reno +44 more locations

Sponsor: Tenax Therapeutics, Inc.

Sex: All·Age: 18 - 85

Code: NCT07288398·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

for Atopic Dermatitis (AD)

Sites in Las Vegas +31 more locations

Sponsor: Enveda Therapeutics

Sex: All·Age: 18 - 75

Code: NCT07298395·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

for Rheumatoid Arthritis

Drug: AZD1163

Sites in Henderson +21 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07276581·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for Non-alcoholic Fatty Liver Disease

Sites in Las Vegas +75 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 75

Code: NCT07221227·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

for Bronchiectasis

Sites in Henderson +30 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 85

Code: NCT07201051·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for Epithelial Ovarian Cancer

Sites in Las Vegas +38 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07218809·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

for Pulmonary Disease, Chronic Obstructive

Drug: Depemokimab

Sites in Las Vegas, Reno +40 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 40 - 75

Code: NCT07177339·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

for Hypoparathyroidism

Drug: Palopegteriparatide

Sites in Reno +6 more locations

Sponsor: Ascendis Pharma Bone Diseases A/S

Sex: All·Age: 18+

Code: NCT07081997·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for Chronic Inflammatory Demyelinating Polyneuropathy

Sites in Las Vegas +32 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18+

Code: NCT07032662·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for Graves' Disease

Drug: IMVT-1402

Sites in Reno +32 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18 - 75

Code: NCT07018323·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

Drug: AZD0780

Sites in Las Vegas +309 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

for REM Sleep Behavior Disorder

Sites in Las Vegas +17 more locations

Sponsor: Yale University

Sex: All·Age: 50 - 80

Code: NCT06996652·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for HER2-positive Gastric Cancer

Drug: Rilvegostomig

Sites in Reno +45 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06764875·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for Heart Failure and Impaired Kidney Function

Drug: Dapagliflozin

Sites in Henderson +109 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06307652·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

for Chronic Obstructive Pulmonary Disease (COPD)

Sites in Las Vegas +67 more locations

Sponsor: AstraZeneca

Sex: All·Age: 40 - 80

Code: NCT06883305·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in Las Vegas +328 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

for Hereditary Angioedema (HAE)

Sites in Las Vegas +12 more locations

Sponsor: Pharvaris Netherlands B.V.

Sex: All·Age: 12+

Code: NCT06679881·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in Las Vegas +28 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06350097·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

for COPD (Chronic Obstructive Pulmonary Disease)

Sites in Las Vegas +133 more locations

Sponsor: AstraZeneca

Sex: All·Age: 40 - 80

Code: NCT06283966·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for Graves' Disease

Drug: IMVT-1402

Sites in Las Vegas +54 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18 - 75

Code: NCT06727604·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

for Growth Hormone Deficiency (GHD)

Sites in Las Vegas +29 more locations

Sponsor: Lumos Pharma

Sex: All·Age: 3 - 11

Code: NCT06948214·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

for Systemic Lupus Erythematosus

1 location in Las Vegas

Sponsor: AstraZeneca

Sex: Female·Age: 18 - 130

Code: NCT06594068·Phase 4·Recruiting·Listed Sep 2024

Apply to this trial